Commonwealth Fund

Affordable, quality health care. For everyone.

The Many Varieties of Universal Coverage

Sara R. Collins
and Roosa Tikkanen

The Commonwealth Fund Recommends

Man-choosing-between-brand-name-drugs-and-generic-drugs
Perverse Incentives: Why Brand-Name Drugs Can Cost Less Than Generics for Medicare Beneficiaries
| Journal Article
Designing the Future of Care for Medicare-Medicaid Enrollees
Designing the Future of Care for Dually Eligible Medicare–Medicaid Enrollees
| To The Point
prescription drug prices binding arbitration
Is Arbitration an Answer for High Drug Prices?
| To The Point
Congressional testimony about consumer health care costs
Testimony: Status of U.S. Health Insurance Coverage and the Potential of Recent Congressional Health Reform Bills to Expand Coverage and Lower Consumer Costs
| Publication

Publication Details

Publication Date: March 6, 2019
Author: Sara R. Collins, Roosa Tikkanen
Topics
Health Care Coverage and Access
Medicare

Tags

Medicare, Universal Coverage, Health Care in the 2020 Election

Experts

Sara Collins

Sara R. Collins

Vice President, Health Care Coverage and Access, The Commonwealth Fund
Roosa Tikkanen

Roosa Tikkanen

Research Associate, International Program in Health Policy and Practice Innovations, The Commonwealth Fund

© 2019 The Commonwealth Fund. All Rights Reserved. Privacy Policy